4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-088105
General Counsel sold 22,500 shares at an average $101.19 ($2,276,850)
- General Counsel acquired 22,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murdock Hunter R. General Counsel | 2025-06-16 | Option exercise 10b5-1 | +7,500 | $29.91 | $224,325 | 7,500 | D |
| Murdock Hunter R. General Counsel | 2025-06-16 | Sale 10b5-1 | −7,500 | $102.42 | $768,150 | 0 | D |
| Murdock Hunter R. General Counsel | 2025-06-17 | Option exercise 10b5-1 | +7,500 | $29.91 | $224,325 | 7,500 | D |
| Murdock Hunter R. General Counsel | 2025-06-17 | Sale 10b5-1 | −7,500 | $100.26 | $751,950 | 0 | D |
| Murdock Hunter R. General Counsel | 2025-06-18 | Option exercise 10b5-1 | +7,500 | $29.91 | $224,325 | 7,500 | D |
| Murdock Hunter R. General Counsel | 2025-06-18 | Sale 10b5-1 | −7,500 | $100.90 | $756,750 | 0 | D |
| Derivatives | |||||||
| Murdock Hunter R. General Counsel | 2025-06-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 44,883 | D | ||
| Murdock Hunter R. General Counsel | 2025-06-17 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 37,383 | D | ||
| Murdock Hunter R. General Counsel | 2025-06-18 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 29,883 | D | ||
| Open-market sales · 22,500 sh · avg $101.19 · $2,276,850 | |||||||
Loading xslF345X05/ownership.xml…